Antiviral and immunostimulating agents.
An antiviral agent with an immunomodulatory effect that specifically suppresses influenza A and B viruses, severe acute respiratory syndrome (SARS). Prevents contact and penetration of viruses into cells by suppressing the fusion of the lipid membrane with cell membranes. It has an interferon-inducing effect, stimulates humoral and cellular immune responses, the phagocytic function of macrophages, and increases the body's resistance to viral infections. Reduces the incidence of complications associated with a viral infection.
Therapeutic efficacy in viral infections is manifested in a decrease in general intoxication and cellular manifestations of the disease, and the duration of the disease is reduced. The preparation belongs to low-toxic preparations (LD50> 4 g / kg), does not have a negative effect on the human body when used in recommended doses.
The preparation is rapidly absorbed in the digestive tract. The maximum concentration is reached 1.2 hours after taking a dose of 50 mg, 1.5 hours after taking a dose of 100 mg. The half-life is 17 - 21 hours. Approximately 40% of the preparation is excreted unchanged in feces (38.9%) and in the urine (0.12%). During the first day, 90% of the administered dose is excreted.
Prevention and treatment of influenza A and B, acute respiratory viral infections, including complicated ones. As part of the complex therapy of chronic bronchitis, pneumonia and recurrent herpes infection.
As part of the complex therapy of acute intestinal infections of rotavirus etiology in children over 12 years old.
Hypersensitivity to the preparation. Children under 12 years of age.
Application during pregnancy or lactation.
No data available.
The ability to influence the reaction rate when driving or operating other mechanisms.
Does not affect.
Children.
The preparation is used in children over 12 years of age.
Applied to children over 12 years of age and adults. It is taken orally 30 minutes before meals. A single dose for children aged 12 years and older - 200 mg.
For non-specific prophylaxis:
with direct contact with patients with influenza and other acute respiratory viral infections:
- children over 12 years old - 200 mg,
during an epidemic of influenza and other acute respiratory viral infections, to prevent (prevent) complications of chronic bronchitis, recurrence of herpes infection:
- children over the age of 12 and adults - 200 mg 2 times a week for 3 weeks.
For treatment
Influenza, other acute respiratory viral infections without complications:
- children over the age of 12 and adults - 200 mg 4 times a day (every 6 hours) for 5 days;
flu, other acute respiratory viral infections with complications (bronchitis, pneumonia and others):
- children over the age of 12 and adults - 200 mg 4 times a day (every 6 hours) for 5 days, then take a single dose once a week for 4 weeks.
In the complex treatment of chronic bronchitis, herpes infection:
- children over the age of 12 and adults - 200 mg 4 times a day (every 6 hours) for 5 - 7 days, then take a single dose 2 times a week for 4 weeks.
Complex therapy of acute intestinal infections of rotavirus etiology in children aged 12 years and older:
- children over the age of 12 and adults - 200 mg 4 times a day (every 6 hours) for 5 days.
Not checked.
Allergic reactions are possible.
Interaction with other medicinal products and other types of interactions.
When the preparation interacted with other preparations, no negative effects were found.
2 years.
Do not use after the expiration date printed on the package.
Store in its original packaging at a temperature not exceeding 25 ° C.
Keep out of the reach of children.